Page last updated: 2024-08-24

sparfloxacin and Pneumonia, Pneumococcal

sparfloxacin has been researched along with Pneumonia, Pneumococcal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brumpt, I; Grassi, GG1
Aubier, M; Geslin, P; Regamey, C; Vercken, JB; Verster, R1
Young, LS1
Azoulay-Dupuis, E; Bédos, JP; Moine, P; Muffat-Joly, M; Pocidalo, JJ; Vallée, E; Veber, B1
Johnson, JR1
Azoulay-Dupuis, E; Bauchet, J; Bedos, JP; Pocidalo, JJ; Vallee, E; Veber, B1

Reviews

1 review(s) available for sparfloxacin and Pneumonia, Pneumococcal

ArticleYear
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Adult; Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Quinolones; Treatment Outcome

1995

Trials

1 trial(s) available for sparfloxacin and Pneumonia, Pneumococcal

ArticleYear
Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Adult; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Penicillins; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae

1998

Other Studies

4 other study(ies) available for sparfloxacin and Pneumonia, Pneumococcal

ArticleYear
A new fluoroquinolone for community-acquired pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Pneumococcal; Quinolones

1998
Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae

1998
Amoxicillin versus sparfloxacin in the treatment of presumed pneumococcal pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:1

    Topics: Amoxicillin; Anti-Infective Agents; Fluoroquinolones; Humans; Penicillins; Pneumonia, Pneumococcal

2000
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred C57BL; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Species Specificity; Streptococcus pneumoniae

1992